Detect™ selected by nih to scale manufacturing of pcr-quality rapid at-home covid-19 test

Guilford, conn.--(business wire)-- #covid19--detect™, inc., a connecticut-based health technology company, announced today that the national institutes of health (nih) has selected the detect™ covid-19 test to receive funding from the highly competitive rapid acceleration of diagnostics initiative (radxsm). the $8.1 million contract will facilitate the development and scale up manufacturing of detect's pcr-quality rapid at-home covid-19 test to meet national testing demand. the detect covid-19 test, curre
BFLY Ratings Summary
BFLY Quant Ranking